Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by Boomskidon Jan 23, 2023 11:53pm
119 Views
Post# 35241474

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is why i love this board

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is why i love this board I was never sure that I would make a lot of money on Bioasis. I was confident that if xB3 worked as hoped that it would be worth a lot of money. It was also clear that I was worried about Bioasis management as early as 2012, and I posted those worries.

I was worried that Bioasis would not prove the value of xB3. They chose not to do that, astonishingly, and I was right to worry about it. I and most others had diminishing concerns that xB3 would fail. All studies that we know of have increased everybody's confidence in xB3. It's a sad thing that management never kept up with the technology.

Are you able to understand the nuance there, Craig? Bioasis could be no more valuable than the effectiveness of both mangement and the technology. We need both. So far? xB3, 98.6, management, 0.

jd
<< Previous
Bullboard Posts
Next >>